•  
  •  
 

Document Type

Original Article

Abstract

Background: A spate of pneumonia cases around the end of 2019 discovered in China, and researchers eventually traced the outbreak to a new coronavirus known as SARS-CoV-2. Patients with COVID-19, whether just suspected or confirmed, may also present with AKI. There seems to be variation in prevalence based on research setting and the percentage of critically ill patients included. However, only a small number of studies focusing on the clinical features of AKI in individuals with COVID-19 infection have been conducted in Egypt. The goal of this study is to provide a description of the result of AKI among COVID-19 patients treated in hospitals affiliated with Al-Azhar University This study was done at Al- Azhar University Hospitals during the period between 1-01-2022 to 30-06-2022 A total of 100 confirmed COVID-19 patients were recruited for this survey. Their anthropometrics and laboratory data were collected. Statistical analyses were conducted to evaluate the outcome of AKI among these COVID-19 positive infection. In all studied patients, there were 22 patients (22%) with direct renal mortality and 56 patients (56%) with mortality due to non-renal causes. There were 46 patients (46%) in RRT need, RRT was done for 28 patients (28%). 8 patients (28.6%) had CRRT, 18 patients (64.3%) had CHD and 2 patient (7.1%) had SLED 10 patients (10%) developed CKD, 6 of them developed ESRD with permanent RRT, while 12 patients (12%) had completely recovered from AKI.AKI among COVID 19 infection patients was correlated with high RRT, and high mortality rate.

Keywords

AKI; COVID-19; Outcome; RRT; ESRD

Download

Share

COinS